Avalon BioVentures II, LP filed a Form D with the SEC on Nov. 12 for a $200 million venture capital fund offering.
The filing names Avalon BioVentures Management, LLC as sponsor and reports $0 sold against the $200 million offering. The issuer is a pooled investment fund, and a first sale has yet to occur.
Allocators screening new venture vintages now have a new vehicle to track, though fee, carry and minimum commitment terms have not been disclosed.
Reported by the Venture Capital desk from SEC EDGAR. Published . Corrections